We’re also authorizing the use of each of the available vaccines as a heterologous (or “mix-and-match”) booster dose in eligible individuals following completion of primary vaccination with a different available COVID-19 vaccine.
The HPTN 083 primary paper and accompanying editorial were just published in @NEJM. The study demonstrated long-acting injectable cabotegravir lowered #HIV incidence among cisgender men and transgender women who have sex with men. Learn more at https://t.co/h00CENsCeT
Across the Jackson Health System hospitals, we currently have 146 inpatients who have tested positive for COVID-19 and of those, 91 percent are unvaccinated.
From our June issue: Novel Agents for the Treatment of Carbapenem-Resistant A baumannii. Thank you @ncg313@JayCdoesID for your great contribution! #IDtwitter#infectiousdiseases
https://t.co/0XFXVZBqa4
Thank you to the Black women in medicine and pharmacy that pour into me, that make every hard day, every hard comment, every moment of impostor syndrome, a bit better. I am forever grateful, and I carry you all with me. @YewyD@BNS_IDPharmD@RobbieLeeAnneC@ID_BugaBoo
If you have a manuscript that needs a home as the residency year is wrapping up, consider submitting to the special issue @jwagsIDPharmD, @KaBar_33 and I are guest-editing!